Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Canadian Pacific Kansas City Ltd. Stock Outperforms Market Despite Losses On The Day

Canadian Pacific Kansas City Ltd. Stock Outperforms Market Despite Losses On The Day

Dow JonesDow Jones2026/08/18 20:31

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Canadian Pacific Kansas City Ltd. CP shed 0.02% to C$130.16 Tuesday, in what proved to be an all-around negative trading session for the Canadian market, with the S&P/TSX Composite Index falling 0.82% to 36,367.93.

Canadian Pacific Kansas City Ltd. closed 1.3% below its 52-week high of C$131.89, which the company achieved on July 20th.

Trading volume of 892,416 shares remained below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

August 18, 2026 16:31 ET (20:31 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%

Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.

智通财经2026/09/21 23:36

700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released

Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.

智通财经2026/09/21 23:31